{"name":"Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.","slug":"uni-pharma-kleon-tsetis-pharmaceutical-laboratories-s-a","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"APOTEL max","genericName":"APOTEL max","slug":"apotel-max","indication":"Mild to moderate pain","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Fe-ASP","genericName":"Fe-ASP","slug":"fe-asp","indication":"Acute lymphoblastic leukemia (ALL)","status":"marketed"}]}],"pipeline":[{"name":"APOTEL max","genericName":"APOTEL max","slug":"apotel-max","phase":"marketed","mechanism":"APOTEL max is a fixed-dose combination of paracetamol (acetaminophen) and an additional analgesic or anti-inflammatory agent that works to reduce pain and fever through multiple pathways.","indications":["Mild to moderate pain","Fever reduction"],"catalyst":""},{"name":"Fe-ASP","genericName":"Fe-ASP","slug":"fe-asp","phase":"marketed","mechanism":"Fe-ASP is an iron-asparaginase conjugate that depletes asparagine while delivering iron supplementation.","indications":["Acute lymphoblastic leukemia (ALL)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE83eXpsSzhNY003d01ObVlpcjM0QkFEaS1MZ1cyREFIekVKdFdQTi1nWHNZMGlzaFNsNEx3NTdjalYxa2tYY3dicHA0dEtMT2xYRXJHSFhZdm05bFVQd3dsRzVRelFlMTNFUmc?oc=5","date":"2025-08-10","type":"pipeline","source":"Wiley Online Library","summary":"From Genome to Geroscience: How DNA Damage Shapes Systemic Decline - Siametis - 2025 - BioEssays - Wiley Online Library","headline":"From Genome to Geroscience: How DNA Damage Shapes Systemic Decline - Siametis - 2025 - BioEssays","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}